Epstein-barr virus immune response in high-risk nasopharyngeal carcinoma families in Greenland

Journal of Medical Virology

Volumn 79, Issue 12, 2007, Pages 1877-1881

  Friborg, Jeppe ^a,h   Jarrett, Ruth F ^b   Liu, Mei Ying ^c,d   Falk, Kerstin I ^e   Koch, Anders ^a   Olsen, Ove R ^f   Duncan, Pamela ^b   Wohlfarht, Jan ^a   Chen, Jen Yang ^c,g   Melbye, Mads ^a  

^a DEPARTMENT OF EPIDEMIOLOGY RESEARCH   (Denmark)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

^c NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^d NATIONAL TAIPEI UNIVERSITY OF NURSING AND HEALTH SCIENCES   (Taiwan)

^e KAROLINSKA INSTITUTE   (Sweden)

^f Sisimiut Medical Center   (Greenland)

^g NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^h STATENS SERUM INSTITUT   (Denmark)

Author keywords

Epstein Barr virus; Immunology; Inuit; Nasopharyngeal carcinoma

Indexed keywords

IMMUNOGLOBULIN A ANTIBODY;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE MARKER; EPSTEIN BARR VIRUS; ESKIMO; FAMILY; FEMALE; GREENLAND; HIGH RISK PATIENT; HUMAN; IMMUNE RESPONSE; INCIDENCE; MALE; MONONUCLEAR CELL; NASOPHARYNX CARCINOMA; PREVALENCE; SERODIAGNOSIS; SEROPREVALENCE; STATISTICAL SIGNIFICANCE; UNDIFFERENTIATED CARCINOMA; VIRUS LOAD;

ADULT; CASE-CONTROL STUDIES; EPSTEIN-BARR VIRUS INFECTIONS; FAMILY; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GREENLAND; HERPESVIRUS 4, HUMAN; HUMANS; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; RISK FACTORS; SEROEPIDEMIOLOGIC STUDIES;

HUMAN HERPESVIRUS 4; MIRIDAE;

EID: 35548982078     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.21014     Document Type: Article

References (24)

1. Chan KC, Lo YM. 2002. Circulating EBV DNA as a tumor marker for nasopharyngeal carcinoma. Semin Cancer Biol 12:489-496.
2. Chien YC, Chen JY, Liu MY, Yang HI, Hsu MM, Chen CJ, Yang CS. 2001. Serologic markers of Epstein-Barr virus infection and nasopharyngeal carcinoma in Taiwanese men. N Engl J Med 345:1877-1882.
3. Deng H, Zeng Y, Lei Y, Zhao Z, Wang P, Li B, Pi Z, Tan B, Zheng Y, Pan W. 1995. Serological survey of nasopharyngeal carcinoma in 21 cities of south China. Chin Med J (Engl) 108:300-303.
4. Friborg J, Koch A, Wohlfarht J, Storm HH, Melbye M. 2003. Cancer in Greenlandic Inuit 1973-1997: A cohort study. Int J Cancer 20:1017-1022.
5. Friborg J, Wohlfahrt J, Koch A, Storm H, Olsen OR, Melbye M. 2005. Cancer susceptibility in nasopharyngeal carcinoma families - a population-based cohort study. Cancer Res 65:8567-8572.
6. Goldgar DE, Easton DF, Cannon-Albright LA, Skolnick MH. 1994. Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands. J Natl Cancer Inst 86:1600-1608.
7. Henle G, Henle W. 1976. Epstein-Barr virus-specific IgA serum antibodies as an outstanding feature of nasopharyngeal carcinoma. Int J Cancer 17:1-7.
8. Ho HC, Ng MH, Kwan HC. 1978. Factors affecting serum IgA antibody to Epstein-Barr viral capsid antigens in nasopharyngeal carcinoma. Br J Cancer 37:356-362.
9. IARC Working Group, i. 1997. Epstein-Barr Virus and Kaposi's Sarcoma. Lyon: World Health Organization, International Agency for research in Cancer.
10. Lennette ET, Rymo L, Yadav M, Masucci G, Merk K, Timar L, Klein G. 1993. Disease-related differences in antibody patterns against EBV-encoded nuclear antigens EBNA 1, EBNA 2 and EBNA 6. Eur J Cancer 29A:1584-1589.
11. Levine PH, Ebbesen P, Connelly RR, Das S, Middleton M, Mestre M. 1982. Complement-fixing antibody to Epstein-Barr virus soluble antigen in populations at high and low risk for nasopharyngeal carcinoma. Int J Cancer 29:265-268.
12. Linde A, Andersson J, Lundgren G, Wahren B. 1987. Subclass reactivity to Epstein-Barr virus capsid antigen in primary and reactivated EBV infections. J Med Virol 21:109-121.
13. Lo YM, Chan AT, Chan LY, Leung SF, Lam CW, Huang DP, Johnson PJ. 2000. Molecular prognostication of nasopharyngeal carcinoma by quantitative analysis of circulating Epstein-Barr virus DNA. Cancer Res 60:6878-6881.
14. MacKenzie J, Gallagher A, Clayton RA, Perry J, Eden OB, Ford AM, Greaves MF, Jarrett RF. 2001. Screening for herpesvirus genomes in common acute lymphoblastic leukemia. Leukemia 15:415-421.
15. Moss DJ, Chan SH, Burrows SR, Chew TS, Kane RG, Staples JA, Kunaratnam N. 1983. Epstein-Barr virus specific T-cell response in nasopharyngeal carcinoma patients. Int J Cancer 32:301-305.
16. Parkin DM, Wheelan SL, Ferlay J, Teppo L, Thomas D. 2002. Cancer Incidence in Five Continents, vol. VIII. Lyon: IARC.
17. Pickard A, Chen CJ, Diehl SR, Liu MY, Cheng YJ, Hsu WL, Sun B, Hsu MM, Chen IH, Chen JY, Yang CS, Mittl BL, Chou SP, Ruggles DD, Goldstein AM, Hildesheim A. 2004. Epstein-Barr virus seroreactivity among unaffected individuals within high-risk nasopharyngeal carcinoma families in Taiwan. Int J Cancer 111:117-123.
18. Raab-Traub N, Rajadurai P, Flynn K, Lanier AP. 1991. Epstein-Barr virus infection in carcinoma of the salivary gland. J Virol 65:7032-7036.
19. Shao JY, Li YH, Gao HY, Wu QL, Cui NJ, Zhang L, Cheng G, Hu LF, Ernberg I, Zeng YX. 2004. Comparison of plasma Epstein-Barr virus (EBV) DNA levels and serum EBV immunoglobulin A/virus capsid antigen antibody titers in patients with nasopharyngeal carcinoma. Cancer 100:1162-1170.
20. Sixbey JW, Yao QY. 1992. Immunoglobulin A-induced shift of Epstein-Barr virus tissue tropism. Science 20:1578-1580.
21. Xu J, Ahmad A, Jones JF, Dolcetti R, Vaccher E, Prasad U, Menezes J. 2000. Elevated serum transforming growth factor beta1 levels in Epstein-Barr virus-associated diseases and their correlation with virus-specific immunoglobulin A (IgA) and IgM. J Virol 74:2443-2446.
22. Yang XR, Goldstein AM, Chen CJ, Rabkin CS, Chen JY, Cheng YJ, Hsu WL, Sun B, Diehl SR, Liu MY, Walters M, Shao W, Ortiz-Conde BA, Whitby D, Elmore SH, Gulley ML, Hildesheim A. 2006. Distribution of Epstein-Barr viral load in serum of individuals from nasopharyngeal carcinoma high-risk families in Taiwan. Int J Cancer 118:780-784.
23. Zeng YX, Jia WH. 2002. Familial nasopharyngeal carcinoma. Semin Cancer Biol 12:443-450.
24. Zeng Y, Zhong JM, Li LY, Wang PZ, Tang H, Ma YR, Zhu JS, Pan WJ, Liu YX, Wei ZN. 1983. Follow-up studies on Epstein-Barr virus IgA/VCA antibody-positive persons in Zangwu County, China. Intervirology 20:190-194.